Genmab — April 2020
-
A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma https://ashpublications.org/blood/article/135/15/1232/441041/A-Tcellredirecting-bispecific-Gproteincoupled
-
-
JNJ-372 is the most advanced Janssen duobody. Any idea when this (if successful) coole
-
Any idea when this could generate any Sales?
-
Didn't know that Talquetamab is tested in combo with dara. https://www.clinicaltrials.gov/ct2/show/NCT04108195?term=daratumumab+talquetamab&draw=2&rank=1
-
Thanks mates. If its 2023 its not that far away. I also remember it was once mentioned that JNJ expect 3 of the Genmab duobodies to have blockbuster potential
-
God morgen.
-
Few comments on the MASTER trial: Impact of autologous hematopoietic cell transplant on measurable MRD in the setting Dara-KRd https://www.ascopost.com/issues/april-10-2020/highlights-from-transplantation-and-cellular-therapy-meetings-of-astct-and-cibmtr/
-
God morgen
-
Test
-
Det er da gået helt i stå her på chatten!!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind